The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 28 | 45.3x | 20.1x | Below average | |
Growth | 38 | 20.0% | 5.6% | Near average | |
Quality | 57 | 14.3% | 7.6% | Near average | |
Safety | 64 | -1.6x | 0.4x | Near average | |
Capital Return | 44 | — | 2.19% | Near average | |
Momentum | 53 | — | — | Near average | |
Sentiment | 52 | — | — | Near average |
Edwards Lifesciences Corporation is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Edwards Lifesciences Corporation shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Analyst data shows a state of complete stability in price forecasts for EW over the past 30 days, as the average price target remained steady at 87.08 dollars despite the stock currently trading at the 86 dollars level. The dispersion in estimates (between 85 and 110 dollars) indicates a valuation gap, but the general consensus remains firm without any downward or upward revisions in the recent period, reflecting analysts' wait for new catalysts.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.